Belite Bio Prepares for Financial Results Webcast Belite Bio will host a webcast today, March 17, 2025, to discuss its financial performance for Q4 and the full year 2024. The company is advancing treatments for retinal diseases, including Stargardt disease. Investors and stakeholders can access the webcast for updates on its lead candidate and ongoing clinical trials.3